Our Vision
Re-defining
Medicine for the Coming
Generation
Curing incurable diseases by re-programming cell fate or function.
Passionate
Reliable
Achievers
Committed
Team players
Innovative
Courageous
Engaged
iRegene's
mission
We are a passionate team committed
to developing first-in-class therapies
for patients suffering from major
incurable diseases. Making fast-acting
and disease-reversing therapies accessible
to patients in the greatest extent
possible is our priority.
Passionate
Achievers
Team players
Courageous
Reliable
Committed
Innovative
Engaged
Next Generation R&D Eco-system, Made by iRegene
iReMeta
Discovering Omics, Powered by AI
iReChem
Deep Learning Assisted Virtual Screening
iReXam
Compounds Validation
iReDita
Gene Editing & Reporter Cell Lines
iReCena
Designing Exosomes for Therapeutics Delivery
Independent Pipelines & Cooperation Pipelines
Project
Indication
POC Pre-Clinical IND Phase I
Phase II Phase III
RIGHT
NouvNeu001
Parkinson′s Disease
2023 H2 Initiate Clinical Trials
NouvNeu003*
Early-onset Parkinson's
2024 H2 Initiate Clinical Trials
NouvNeu002*
Ischemic Stroke
2024 H2 IND
NouvSight001
Retinal Degenerative Diseases
NouvHepa001
Liver Diseases
Contact
iReMeta
Discovery Platform with the aid of AI Algorithms
• Omic analysis
• Information Learned from Patients
• Precise and distinctive models
Address
No. 9, Gaokeyuan 3rd Road, East Lake High-tech Development Zone, Wuhan
Tel.
(+86) 027-65522933 (+86) 027-59338180
iregene@iregene.com
Address
218 Sang Tian Rd. BLDG 2 Rm.501 BioBAY Phase 2, Su Zhou Industrial Park Su Zhou, Jiang Su Province, 215000, China
Tel.
(+86) 186-9612-5803
iregene@iregene.com
Address
8000 Aarhus C, Denmark
iregene@iregene.com
Address
160 Robinson Road,#14-04 Singapore Business Federation Centre – Singapore 068914
iregene@iregene.com